Provided by Tiger Trade Technology Pte. Ltd.

Summit Therapeutics PLC

14.44
+0.82006.02%
Volume:2.27M
Turnover:31.82M
Market Cap:11.52B
PE:-12.92
High:14.48
Open:13.38
Low:13.37
Close:13.62
52wk High:29.23
52wk Low:12.07
Shares:797.75M
Float Shares:152.34M
Volume Ratio:0.52
T/O Rate:1.49%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1177
EPS(LYR):-1.4439
ROE:-192.50%
ROA:-101.61%
PB:18.29
PE(LYR):-10.00

Loading ...

Summit Therapeutics (SMMT) Receives a Rating Update from a Top Analyst

TIPRANKS
·
May 03

Summit Therapeutics Flags Significant Going-Concern Risk Amid Cash Shortfall and Uncertain Financing

TIPRANKS
·
May 02

Summit Therapeutics Shares Fall After 1Q Loss Widens

Dow Jones
·
May 02

BUZZ-Summit Therapeutics falls after interim results from lung cancer study

Reuters
·
May 02

Summit Therapeutics Stock Dips After Q1 Financial Report

Benzinga Earnings
·
May 01

Summit Therapeutics falls -27.4%

TIPRANKS
·
May 01

Goldman Sachs Remains a Buy on Summit Therapeutics (SMMT)

TIPRANKS
·
May 01

Summit Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 01

Summit Therapeutics Q1 FY26 net loss widens to $189.4 million; operating expenses rise to $195.2 million

Reuters
·
May 01

Summit Therapeutics Q1 adjusted loss narrows despite higher R&D costs

Reuters
·
May 01

Summit Therapeutics Q1 Adjusted EPS USD -0.15 VS. Ibes Estimate USD -0.18

THOMSON REUTERS
·
May 01

Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2026

THOMSON REUTERS
·
May 01

Electric Vehicle Adoption Reaches 'Tipping Point' Globally, Trend Deemed Self-Sustaining

Deep News
·
Apr 26

Summit Therapeutics put volume heavy and directionally bearish

TIPRANKS
·
Apr 23

Summit partner selection for ASCO plenary signals strong OS, says Leerink

TIPRANKS
·
Apr 22

Summit partner selection for ASCO ‘likely a major positive,’ says Guggenheim

TIPRANKS
·
Apr 22

IonQ, Oklo, And Robinhood Are Among the Top 10 Large-Cap Gainers Last Week (April 13-April 17): Are the Others in Your Portfolio?

Benzinga_recent_news
·
Apr 19

Evercore ISI Reaffirms Their Buy Rating on Summit Therapeutics (SMMT)

TIPRANKS
·
Apr 17

Summit Therapeutics Inc Stock (SMMT) Moved Up by 12.03% on Apr 16: Drivers Behind the Movement

TradingKey
·
Apr 17

Summit Therapeutics Inc : Stifel Initiates Coverage With Buy Rating; Price Target $45

THOMSON REUTERS
·
Apr 08